AAAAAA
Results:
1-18
|
Results: 18
Authors:
CRISMON ML
FANKHAUSER MP
HINKLE GH
JANN MW
JUNI H
LOVE RC
RAY MD
STIMMEL GL
WELLS BG
Citation: Ml. Crismon et al., PSYCHIATRIC PHARMACY PRACTICE SPECIALTY CERTIFICATION PROCESS, American journal of health-system pharmacy, 55(15), 1998, pp. 1594-1598
Authors:
MILLER AL
CHILES JA
RUSH AJ
CRISMON ML
TOPRAC MG
SHORESWILSON KL
Citation: Al. Miller et al., MEDICATION ALGORITHMS FOR SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 160-160
Authors:
CRISMON ML
Citation: Ml. Crismon, PHARMACOKINETICS AND DRUG-INTERACTIONS OF CHOLINESTERASE-INHIBITORS ADMINISTERED IN ALZHEIMERS-DISEASE, Pharmacotherapy, 18(2), 1998, pp. 47-54
Authors:
KHACHATURIAN ZS
CUMMINGS JL
CRISMON ML
JAN M
MEEK PD
BECK C
Citation: Zs. Khachaturian et al., NEW ADVANCES IN THE TREATMENT OF ALZHEIMERS-DISEASE - PANEL DISCUSSION, Pharmacotherapy, 18(2), 1998, pp. 79-82
Authors:
STANISLAV SW
CRISMON ML
CHILDS NL
Citation: Sw. Stanislav et al., CEREBROSPINAL-FLUID MONOAMINE METABOLITES AND GLUCOSE-METABOLISM IN POSTTRAUMATIC AGGRESSION, Biological psychiatry, 43(8), 1998, pp. 619-621
Authors:
SUPPES T
SWANN A
CRISMON ML
SHON S
RUSH AJ
ALTSHULER KZ
Citation: T. Suppes et al., WILL MEDICATION ALGORITHMS PROVIDE ADEQUATE INFORMATION ON TREATMENT RESPONSE IN BIPOLAR DISORDER, Psychopharmacology bulletin, 33(3), 1997, pp. 591-591
Authors:
STANISLAV SW
CRISMON ML
CHILDS N
LINNOILA M
Citation: Sw. Stanislav et al., CSF MONOAMINE METABOLITES AND POSTTRAUMATIC AGGRESSION, Biological psychiatry, 41, 1997, pp. 357-357
EFFECTS OF SWITCHING INPATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA FROM CLOZAPINE TO RISPERIDONE
Authors:
STILL DJ
DORSON PG
CRISMON ML
POUSSON C
Citation: Dj. Still et al., EFFECTS OF SWITCHING INPATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA FROM CLOZAPINE TO RISPERIDONE, Psychiatric services, 47(12), 1996, pp. 1382-1384
Authors:
PABIS DJ
DORSON PG
CRISMON ML
Citation: Dj. Pabis et al., EVALUATION OF INPATIENT DEPOT ANTIPSYCHOTIC PRESCRIBING, The Annals of pharmacotherapy, 30(12), 1996, pp. 1381-1386
Authors:
GIDAL BE
CRISMON ML
WAGNER ML
FAGAN SC
PRIVITERA MD
DALMADYISRAEL C
GRAVES NM
Citation: Be. Gidal et al., CURRENT DEVELOPMENTS IN NEUROLOGY .2. ADVANCES IN THE PHARMACOTHERAPYOF ALZHEIMER-DISEASE, PARKINSON DISEASE, AND STROKE, The Annals of pharmacotherapy, 30(12), 1996, pp. 1446-1451
Authors:
GIDAL BE
WAGNER ML
PRIVITERA MD
DALMADYISRAEL C
CRISMON ML
FAGAN SC
GRAVES NM
Citation: Be. Gidal et al., CURRENT DEVELOPMENTS IN NEUROLOGY .1. ADVANCES IN THE PHARMACOTHERAPYOF HEADACHE, EPILEPSY, AND MULTIPLE-SCLEROSIS, The Annals of pharmacotherapy, 30(11), 1996, pp. 1272-1276
Authors:
CRISMON ML
Citation: Ml. Crismon, TACRINE - 1ST DRUG APPROVED FOR ALZHEIMERS-DISEASE, The Annals of pharmacotherapy, 28(6), 1994, pp. 744-751
Authors:
EGGERT AE
CRISMON ML
DORSON PG
TAYLOR RL
Citation: Ae. Eggert et al., CLOZAPINE RECHALLENGE AFTER MARKED LIVER-ENZYME ELEVATION, Journal of clinical psychopharmacology, 14(6), 1994, pp. 425-426
Authors:
GARCIA G
CRISMON ML
DORSON PG
Citation: G. Garcia et al., SEIZURES IN 2 PATIENTS AFTER THE ADDITION OF LITHIUM TO A CLOZAPINE REGIMEN, Journal of clinical psychopharmacology, 14(6), 1994, pp. 426-428
Authors:
STANISLAV SW
FABRE T
CRISMON ML
CHILDS A
Citation: Sw. Stanislav et al., BUSPIRONES EFFICACY IN ORGANIC-INDUCED AGGRESSION, Journal of clinical psychopharmacology, 14(2), 1994, pp. 126-130
Authors:
EGGERT AE
CRISMON ML
DORSON PG
Citation: Ae. Eggert et al., LACK OF EFFECT OF FLUOXETINE ON PLASMA CLOZAPINE CONCENTRATIONS, The Journal of clinical psychiatry, 55(10), 1994, pp. 454-455
Authors:
STANISLAV SW
BARKER K
CRISMON ML
CHILDS A
Citation: Sw. Stanislav et al., EFFECT OF A CLINICAL PSYCHOPHARMACY CONSULTATION SERVICE ON PATIENT OUTCOMES, American journal of hospital pharmacy, 51(6), 1994, pp. 778-781
Authors:
MICHALS ML
CRISMON ML
ROBERTS S
CHILDS A
Citation: Ml. Michals et al., CLOZAPINE RESPONSE AND ADVERSE-EFFECTS IN 9 BRAIN-INJURED PATIENTS, Journal of clinical psychopharmacology, 13(3), 1993, pp. 198-203
Risultati:
1-18
|